NTRK1 and thyroid gland carcinoma: MAPK and PI3K/AKT pathways are dependent on activity of mutually exclusive RAS, BRAF and RET/PTC point mutations (BRAF/RAS/PIK3CA) and rearrangements (RET/PTC and TRK) which drive thyroid cancer oncogenesis.